Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | VDR | P11473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31572848 | 0.81 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL30769721 | 0.81 | ATM (0.43) | — | |
| SCHEMBL27035496 | 0.81 | ATM (0.43) | — | |
| SCHEMBL31463685 | 0.81 | ALDH1A1 (0.39) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL31463696 | 0.81 | ALDH1A1 (0.39) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL22027093 | 0.80 | ALDH1A1 (0.39) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL21123753 | 0.80 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL31330374 | 0.80 | ALDH1A1 (0.38) | ALDH1A1CYP1A2CYP2C9GAAKMT2A | |
| SCHEMBL21805203 | 0.80 | CHRM1 (0.42) | ALDH1A1CYP1A2CYP2C9GAAMAPT | |
| SCHEMBL30519448 | 0.80 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C9GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233837-A1 | 4H-PYRIMIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES FOR USE AS NLRP3 INFLAMMASOME INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDER | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-11-13 | — | — | WO | disclosed |
| EP-4543544-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | Biogen MA Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119866338-A | Tyrosine kinase 2 inhibitors and uses thereof | 渤健马萨诸塞州股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| WO-2023250064-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2023-12-28 | — | — | WO | disclosed |